Intraoperative neuromonitoring (IONM) is very crucial in terms of any surgical intervention to avoid or reduce the chances of risk associated with the damage of neurological function. The fundamental principle of intraoperative neuromonitor is to track the electrical potential during surgical procedures of neurological, cardiovascular or orthopedic surgery. IONM thus helps to prevent complications like paralysis or weakness in muscle or other nerve functions. According to the estimation of WHO, 266.2 to 359.5 million surgical procedures were performed around the globe which increased sharply by 38% over a period of eight years. The rising trend of surgeries contribute largely to the growth of intraoperative neuromonitoring market. Consideration of IONM is important due to better surgical outcome, increasing number of successful surgical procedures and patient safety during surgery.

The intraoperative neuromonitoring market is growing exponentially on account of increasing healthcare expenditure, increasing concern for patient safety, government initiatives for healthcare infrastructure development, and favorable reimbursement policies. The rising geriatric population, increasing prevalence of chronic diseases are the main driving forces behind the growth of intraoperative neuromonitoring market. However, the lack of skilled health professional and lack of awareness may pose challenge to the growth of the intraoperative neuromonitor market. 

The purpose of this research study titled ‘Intraoperative Neuromonitoring Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global intraoperative neuromonitoring market. This report presents and analyzes the major trends prevalent in the global intraoperative neuromonitoring market and the market size and forecast.

This report categorizes the global scar treatment market in terms of source type, application and geographical distribution. On the basis of source type, the intraoperative neuromonitoring market is classified into insourced intraoperative monitoring and outsourced intraoperative monitoring.

Intraoperative neuromonitoring has wide application in various surgeries to prevent the post-operative complications related to nervous system. Based on the application the IONM market can be segmented as follows:

• Spinal surgery
• Neurological Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• ENT Surgery
• Others

Geographically, the intraoperative neuromonitoring market is best understood by segmenting the market into five major regions and chief region level markets as follows:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • Rest of Asia Pacific
• Latin America Middle East and Africa
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of type of device, application type and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global intraoperative neuromonitoring market. Competition assessment tools such as, major agreements, partnerships and collaborations, market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the intraoperative neuromonitoring market. The key players profiled in this report are Medtronic plc., Computational Diagnostics, Inc., NuVasive, Inc., Inomed Medizintechnik GmbH, Accurate Monitoring LLC, Nihon Kohden Corporation, Moberg Research, Inc. and others.

Intraoperative neuromonitors (IONM) are used to record real time status of nervous system to avoid the detrimental effect associated with the damage of nervous system during high-risk spinal, neurological, cardiovascular, orthopedic or other surgeries. The high level patient safety is the main concern and this fact attributes to the growth of intraoperative neuromonitoring market. Depending on the various source, the intraoperative neuromonitors can be categorized as follows:

• Insourced IONM
• Outsourced IONM

Insourced intraoperative neuromonitors is when IONM purchased by medical centers and handled by the surgeons or hospital administration directly, whereas outsourced IONM facility is when the equipment is outsourced to third party agent who operates independently.

Owing to the increasing demand for intraoperative neuromonitors to continuously monitor the neuronal function for patient safety purpose and the easy accessibility, the insourced IONM is predicted to witness significant growth. However, the cost and maintenance associated with the insourced IONM in turn drive the growth of outsourced IONM. On contrary, outsourced IONM are much cost effective compared to insourced, as single equipment is able to provide its service to multiple medical centers and hospital. The improved insights of outsourced IONM handled by highly qualified, trained and standard professionals reduce the capital cost of hospitals and other medical centers by hiring specialists for the insourced IONM. All these factors are expected to contribute enormous growth to the outsourced intraoperative neuromonitoring market in forecasting periods.

The intraoperative neuromonitor (IONM) is a useful technique to assess the neuronal function in real time manner in high-risk surgeries like neurological surgeries, spinal surgeries, cardiovascular surgeries, orthopedic surgeries or others. The continuous assessment of nervous system during surgery is crucial to improve patient safety.

IONM has a wide application in various surgical procedure for safety management to reduce post-operative complications regarding injury in nervous system. On the basis of application, the intraoperative neuromonitoring market is classified as below:

• Spinal surgery
• Neurological Surgery
• Cardiovascular Surgery
• Orthopedic Surgery
• ENT Surgery
• Others

Among all the surgeries, the neurosurgeries and spinal surgeries are expected to hold the major share of the intraoperative neuromonitoring market. The increasing procedure volume of neurosurgery and spine surgery fuel the growth of the intraoperative neuromonitoring market. The importance of identification of neural activities at the time of surgery helps to take immediate interventions if there is any nervous system injury and prevent further complications. Research study showed the reduction in number of poor surgical results while using intraoperative neuromonitors.

Rising incidences of osteoarthritis, osteoporosis with increasing geriatric population drive the orthopedic surgery mostly joint replacement or reconstruction procedures. The monitoring using IONM throughout the course of elbow and shoulder arthroplasty, total knee replacement or other orthopedic surgery is therefore vital to protect nerve from damage, blood clot or any artery injury.

Due to increasing geriatric population, the problems of deafness, hearing loss or eye problems is growing and so the ENT surgical intervention. ENT surgeries are complex in nature and the involvement of neuromonitoring serves as better patient outcome with diminished risk.

Geographically, the global intraoperative neuromonitoring market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is predicted to have the largest market share in intraoperative neuromonitoring market followed by Europe. The well-developed healthcare infrastructure, increasing demand for neurologic care, rising patient safety, presence of major players of intraoperative neuromonitoring devices attribute to the dominance of North American region.  The huge number of population suffering from neurologic disorders, emerging medical tourism and developing healthcare infrastructure fuel the growth of the intraoperative neuromonitoring market in Asia-Pacific region and it is expected to face substantial growth in upcoming periods due to the growing trend of health awareness.

The detailed regional classification of the global intraoperative neuromonitoring market is as follows:

• North America (U.S. & Canada)
• Europe (Germany, U.K., France, Spain, Italy and Rest of Europe)
• Asia Pacific (China, India, Japan and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East and Africa (GCC and Rest of Middle East and Africa)